In this study, the anti-PD-1 antibody not only did not inhibit tumor growth, but it also led to the mice harboring many more T cells expressing PD-1, LAG-3, and TIGIT compared to the non-treatment mice. This evidence concerns the gene LAG3 and neoplasm.